Within the Serotonin Receptor Signaling pathway, the downstream effects of the DEGs in BE-treated mice were found to activate depressive-like behavior, anxiety, and apoptosis and inhibit neuronal excitation and survival of neurons through the upregulation of transcription factor CREB and downregulation of AKT as shown in Figure 6A. This evidence concerns the gene CREB1 and Anxiety.